Esperion Therapeutics Inc
SWB:0ET
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
E
|
Esperion Therapeutics Inc
SWB:0ET
|
US |
|
Coronado Global Resources Inc
ASX:CRN
|
AU |
|
Amplitude Energy Ltd
F:CDP0
|
AU |
|
E
|
Estrima SpA
MIL:BIRO
|
IT |
|
Rushnet Inc
OTC:RSHN
|
US |
|
C
|
Chorus Ltd
OTC:CHRUF
|
NZ |
|
V
|
Vertex Pharmaceuticals Inc
XMUN:VX1
|
US |
|
Elekta AB (publ)
OTC:EKTAF
|
SE |
|
M
|
Mckesson Corp
XBER:MCK
|
US |
|
Gentili Mosconi SpA
F:Z5A
|
IT |
Wall St Price Targets
0ET Price Targets Summary
Esperion Therapeutics Inc
According to Wall Street analysts, the average 1-year price target for 0ET is 2.559 EUR with a low forecast of 1.551 EUR and a high forecast of 2.971 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is 0ET's stock price target?
Price Target
2.559
EUR
According to Wall Street analysts, the average 1-year price target for 0ET is 2.559 EUR with a low forecast of 1.551 EUR and a high forecast of 2.971 EUR.
What is the Revenue forecast for Esperion Therapeutics Inc?
Projected CAGR
3%
The compound annual growth rate for Revenue over the next 8 years is 3%.
What is the Gross Profit forecast for Esperion Therapeutics Inc?
Projected CAGR
29%
The compound annual growth rate for Gross Profit over the next 5 years is 29%.
What is the Operating Income forecast for Esperion Therapeutics Inc?
Projected CAGR
28%
The compound annual growth rate for Operating Income over the next 8 years is 28%.
